Prognostic significance of bcl-2 expression in chronic lymphocytic leukemia.

被引：0
|
作者：
Mapara, MY
Bommert, K
Bargou, R
Daniel, PT
Stilgenbauer, S
Benner, A
Lichter, P
Dorken, B
Dohner, H
机构：
[1] HUMBOLDT UNIV BERLIN,VIRCHOW KLINIKUM,ROBERT ROSSLE KLIN,BERLIN,GERMANY
[2] MAX DELBRUCK CTR MOL MED,BERLIN,GERMANY
[3] UNIV HEIDELBERG,DEPT INTERNAL MED,D-6900 HEIDELBERG,GERMANY
[4] GERMAN CANC RES CTR,D-6900 HEIDELBERG,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [41] Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia
    Jewell, AP
    LEUKEMIA & LYMPHOMA, 1996, 21 (1-2) : 43 - +
  • [42] Correlation of Bax, bcl-2 and MDM-2 expression with drug sensitivity in chronic lymphocytic leukemia (CLL).
    Daeninck, PJ
    Begleiter, A
    Verburg, L
    Lee, K
    Williams, G
    Israels, LG
    Johnston, JB
    BLOOD, 1995, 86 (10) : 1367 - 1367
  • [43] Global analysis of gene expression in chronic lymphocytic leukemia.
    Gribbin, TE
    DeanMcKinney, T
    BLOOD, 1997, 90 (10) : 2333 - 2333
  • [44] Venetoclax, the First BCL-2 Inhibitor for Use in Patients With Chronic Lymphocytic Leukemia
    Seymour, John
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 440 - 443
  • [45] The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    Benjamin L. Lampson
    Matthew S. Davids
    Current Hematologic Malignancy Reports, 2017, 12 : 11 - 19
  • [46] The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    Lampson, Benjamin L.
    Davids, Matthew S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (01) : 11 - 19
  • [47] Prognostic significance of BCL6 and KI67 in patients with chronic lymphocytic leukemia
    Elgammal, Maha Mohamed Adel
    El-Halawani, Nabil Ahmed
    El-Sorady, Manal Abd El-Sattar
    El-Maghraby, Shereen Mohamed
    Sallam, Ghada Said Mahmoud
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (04): : 179 - 183
  • [48] THE ROLE OF BCL-2 IN THE PATHOGENESIS OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    SCHENA, M
    GOTTARDI, D
    GHIA, P
    LARSSON, LG
    CARLSSON, M
    NILSSON, K
    CALIGARISCAPPIO, F
    LEUKEMIA & LYMPHOMA, 1993, 11 (3-4) : 173 - 179
  • [49] Prognostic significance of serum thymidine kinase (sTK) levels and p27Kip1 expression in chronic lymphocytic leukemia.
    Levy, V
    Nataf, J
    Zompi, S
    Thomas, F
    Brouzes, C
    Casadevall, N
    Hallek, M
    Delmer, A
    Ajchenbaum-Cymbalista, F
    BLOOD, 1999, 94 (10) : 312A - 312A
  • [50] Expression of BCL-2 and FAS in chronic myelogenous leukemia (CML).
    Albitar, M
    Kantarijan, H
    Manshouri, T
    OBrien, S
    Andreeff, M
    Kornblau, S
    Beran, M
    Keating, M
    Talpaz, M
    BLOOD, 1997, 90 (10) : 3983 - 3983
12345